Word: tumorous
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Researchers at the Dana-Farber Cancer Institute in the U.S. and the Helsinki and Turku Universities in Finland are already trying Glivec on a rare abdominal cancer called GIST (for gastrointestinal stromal tumor). More common malignancies, such as cancers of the breast and colon, arise as a result of several genetic accidents and so are unlikely to respond to Glivec. But at the very least, the drug's preliminary successes have given cancer researchers promising avenues to pursue. And sometimes that...
...weeks in advance. But the native New Yorker was surprised to learn last December that the next available opening wasn't until sometime in April. Sperling reminded the office staff that she has a family history of breast cancer. "Three or four months could mean the difference between a tumor that's localized and one that's spread into the lymph nodes," she recalls thinking. "I called them every day for a week, and they kept saying there were no exceptions...
Screening for breast tumors is a bit like searching for a penny in a sandstorm. Radiologists look for specks of calcium no bigger than a grain of sand; in a certain pattern, the specks could indicate a tumor. The dense tissue of the breast, particularly in younger women, makes it difficult to isolate these spots on fixed X-ray film, so it's not surprising that doctors reading mammograms pick up only about 85% of the tumors that are there...
...deadwood, relying on stunt casting, gunshots in the corridors, tearjerking storylines and ever-more-Job-like afflictions for its long-suffering staff. With Anthony Edwards announcing his departure in 2002, the writers have more than a year to slowly and mawkishly kill his Dr. Mark Greene with that brain tumor. ER isn't in mortal danger (CBS says it would be content to pick up a few ratings points), but consider this CBS's chance to do good for the ER-weary by doing well for its own schedule...
...perhaps the most novel vaccine, drugmakers at Progenics Pharmaceuticals and Cytogen are using viruses to deliver "naked" DNA directly into the body to fight prostate cancer. Containing the genetic instructions for making a common tumor protein called prostate-specific membrane antigen (PSMA), the DNA triggers a wholesale immune attack on all cells containing the antigen. Having succeeded in animal studies, the vaccine will soon move into human trials...